Editorial: Insights Into Acromegaly Complications.
作者信息
Badiu Corin, Witek Przemyslaw
机构信息
Department of Endocrinology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, and National Institute of Endocrinology, Bucharest, Romania.
Department of Internal Medicine, Endocrinology and Diabetes, Mazovian Brodno Hospital, Warsaw Medical University, Warsaw, Poland.
出版信息
Front Endocrinol (Lausanne). 2022 Jun 27;13:905145. doi: 10.3389/fendo.2022.905145. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Insights Into Acromegaly Complications.社论：肢端肥大症并发症的见解
Front Endocrinol (Lausanne). 2022 Jun 27;13:905145. doi: 10.3389/fendo.2022.905145. eCollection 2022.
2
Sleep apnoea in treated acromegaly: relative frequency and predisposing factors.
Clin Endocrinol (Oxf). 1996 Nov;45(5):563-9. doi: 10.1046/j.1365-2265.1996.00852.x.
3
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly.奥曲肽对肢端肥大症患者睡眠呼吸暂停及舌体积（磁共振成像）的影响。
Eur J Endocrinol. 2004 Sep;151(3):309-15. doi: 10.1530/eje.0.1510309.
4
Sleep apnoea in acromegaly.肢端肥大症中的睡眠呼吸暂停
Br Med J. 1980 Mar 29;280(6218):894-7. doi: 10.1136/bmj.280.6218.894.
5
Sleep apnoea in acromegaly--prevalence, pathogenesis and therapy. Report on two cases.肢端肥大症中的睡眠呼吸暂停——患病率、发病机制及治疗。两例报告。
Presse Med. 1994;23(26):1203-8.
6
Obstructive sleep apnoea in acromegaly: the role of craniofacial changes.肢端肥大症中的阻塞性睡眠呼吸暂停：颅面改变的作用。
Eur Respir J. 1999 Jul;14(1):196-202. doi: 10.1034/j.1399-3003.1999.14a33.x.
7
Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly.培维索孟控制疾病对活动性肢端肥大症患者睡眠呼吸暂停及舌体积的影响。
Eur J Endocrinol. 2009 Dec;161(6):829-35. doi: 10.1530/EJE-09-0694. Epub 2009 Sep 22.
8
Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity.长效善宁对肢端肥大症患者睡眠呼吸暂停的影响：与头颅计算机断层扫描测量法及激素活性的相关性
Clin Endocrinol (Oxf). 2001 Oct;55(4):477-83. doi: 10.1046/j.1365-2265.2001.01358.x.
9
Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors.
Clin Endocrinol (Oxf). 1987 Dec;27(6):649-54. doi: 10.1111/j.1365-2265.1987.tb02947.x.
10
Improvement of sleep apnoea due to acromegaly during short-term treatment with octreotide.
J Intern Med. 1994 Aug;236(2):231-5. doi: 10.1111/j.1365-2796.1994.tb01288.x.
本文引用的文献
1
Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegaly.长效兰瑞肽制剂在肢端肥大症中的药理学和安全性特征。
Expert Rev Clin Pharmacol. 2021 Dec;14(12):1551-1560. doi: 10.1080/17512433.2021.1986004. Epub 2021 Nov 8.
2
Quality of Life in Patients with Acromegaly - A Romanian Single Center Cross-Sectional Study.肢端肥大症患者的生活质量——一项罗马尼亚单中心横断面研究。
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(1):42-50. doi: 10.4183/aeb.2021.42.
3
Global epidemiology of acromegaly: a systematic review and meta-analysis.肢端肥大症的全球流行病学：系统评价和荟萃分析。
Eur J Endocrinol. 2021 Jul 1;185(2):251-263. doi: 10.1530/EJE-21-0216.
4
Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas.术前生长抑素受体配体治疗不影响生长激素分泌型垂体大腺瘤的肿瘤质地。
Endocr Connect. 2021 Jan;10(1):102-109. doi: 10.1530/EC-20-0414.
Zotero 插件